Company Filing History:
Years Active: 1999-2003
Title: Howard O Fearnhead: Innovator in Apoptosis Research
Introduction
Howard O Fearnhead is a notable inventor based in Huntington Station, NY (US). He has made significant contributions to the field of apoptosis research, particularly in identifying compounds that can modulate this critical biological process. With a total of 3 patents to his name, Fearnhead's work has implications for treating various diseases, including cancer and neurodegenerative disorders.
Latest Patents
Fearnhead's latest patents focus on innovative methods for identifying compounds that influence apoptosis in transformed cells. One of his key inventions is a cell-free assay that utilizes oncogene-induced apoptosis to identify inhibitors of apoptosis in drug-resistant cells. This method not only aims to selectively activate apoptosis in transformed cells but also provides a means to inhibit apoptosis in other cell types. The invention is particularly relevant for developing new drugs targeting defective apoptotic machinery associated with diseases such as cancer and neurodegenerative conditions like Huntington's Disease and Alzheimer's Disease.
Career Highlights
Fearnhead is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has been instrumental in advancing our understanding of the biochemical mechanisms underlying apoptosis. Through his innovative approaches, he has contributed to the development of potential therapeutic strategies for diseases characterized by dysfunctional apoptotic processes.
Collaborations
Fearnhead has collaborated with notable colleagues in his field, including Mila Elena McCurrach and Scott William Lowe. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Howard O Fearnhead's contributions to apoptosis research exemplify the importance of innovation in addressing complex medical challenges. His patents and ongoing work continue to pave the way for new therapeutic options in the fight against cancer and neurodegenerative diseases.